Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas
Cardiovascular Research

Abstract
The coxsackievirus B3 (CVB3) mouse myocarditis model is the standard model for investigation of virus-induced myocarditis but the pancreas, rather than the heart, is the most susceptible organ in mouse. The aim of this study was to develop a CVB3 mouse myocarditis model in which animals develop myocarditis while attenuating viral infection of the pancreas and the development of severe pancreatitis.
We developed the recombinant CVB3 variant H3N-375TS by inserting target sites (TS) of miR-375, which is specifically expressed in the pancreas, into the 3ʹUTR of the genome of the pancreo- and cardiotropic CVB3 variant H3.
In this study, we demonstrate that by use of the miR-375-sensitive CVB3 variant H3N-375TS, CVB3 myocarditis can be established without the animals developing severe systemic infection and pancreatitis. As the H3N-375TS myocarditis model depends on pancreas-attenuated H3N-375TS, it can easily be used in different mouse strains and for various applications.
Contributors

Sandra Pinkert
Author

Markian Pryshliak
Author

Kathleen Pappritz
Author

Klaus Knoch
Author

Ahmet Hazini
Author

Babette Dieringer
Author

Katrin Schaar
Author

Fengquan Dong
Author

Luisa Hinze
Author

Jie Lin
Author

Dirk Lassner
Author

Robert Klopfleisch
Author

Michele Solimena
Author

Ziya Kaya
Author

Muhammad El-Shafeey
Author

Antje Beling
Author

Jens Kurreck
Author

Sophie Van Linthout
Author

Karin Klingel
Author

Henry Fechner
Author
You may be interested in




